You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Chapter title |
Evodiamine and Its Role in Chronic Diseases
|
---|---|
Chapter number | 14 |
Book title |
Drug Discovery from Mother Nature
|
Published in |
Advances in experimental medicine and biology, October 2016
|
DOI | 10.1007/978-3-319-41342-6_14 |
Pubmed ID | |
Book ISBNs |
978-3-31-941341-9, 978-3-31-941342-6
|
Authors |
Qunyou Tan, Jingqing Zhang |
Editors |
Subash Chandra Gupta, Sahdeo Prasad, Bharat B. Aggarwal |
Abstract |
Evodiamine (EVO) is a major alkaloid compound extracted from the dry unripened fruit Evodiae fructus (Evodia rutaecarpa Benth., Rutaceae). EVO has a variety of pharmacological activities, such as anti-obesity, anti-allergenic, analgesic, anti-tumor, anti-ulcerogenic, and neuroprotective activities. EVO has varying efficacies in animal models and humans. Here, the physicochemical properties of EVO are presented, and the EVO's functions and mechanisms of action in various chronic diseases are reviewed. EVO is worth exploring in more depth in the future for its potential use in various chronic diseases. |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 32 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 16% |
Student > Doctoral Student | 4 | 13% |
Student > Bachelor | 4 | 13% |
Student > Ph. D. Student | 3 | 9% |
Other | 2 | 6% |
Other | 2 | 6% |
Unknown | 12 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 22% |
Biochemistry, Genetics and Molecular Biology | 5 | 16% |
Nursing and Health Professions | 2 | 6% |
Chemistry | 2 | 6% |
Agricultural and Biological Sciences | 1 | 3% |
Other | 2 | 6% |
Unknown | 13 | 41% |